A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer

Oncologist

Volumn 20, Issue 1, 2015, Pages 13-

  Niravath, Polly ^a   Tham, Yee Lu ^a   Wang, Tao ^a   Rodriguez, Angel ^b   Foreman, Claudette ^a   Hilsenbeck, Susan G ^a   Elledge, Richard ^c   Rimawi, Mothaffar ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; SUNITINIB; DEOXYCYTIDINE; FLUOROURACIL; INDOLE DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CLINICAL ARTICLE; DISEASE COURSE; FATIGUE; HUMAN; NAUSEA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; WHOLE BODY RADIATION; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; BREAST NEOPLASMS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SECONDARY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CAPECITABINE; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INDOLES; PYRROLES;

EID: 84921318186     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0278     Document Type: Article

References (0)